Patent details

EP3453387 Title: DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

Basic Information

Publication number:
EP3453387
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP182010629
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
French Title of Invention:
POSOLOGIE D'UN AGONISTE DU RÉCEPTEUR S1P
German Title of Invention:
DOSIERUNGSPLAN FÜR EINEN S1P-REZEPTORAGONISTEN
SPC Number:

Dates

Filing date:
21/12/2009
Grant date:
03/06/2020
EP Publication Date:
13/03/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/06/2020
EP B1 Publication Date:
03/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/12/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/05/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
23/07/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LOOBY, Michael
Address:
Switzerland (CH)

2

Name:
DUMORTIER, Thomas
Address:
Switzerland (CH)

3

Name:
SCHMOUDER, Robert
Address:
United States (US)

4

Name:
DAVID, Olivier
Address:
Switzerland (CH)

Priority

1

Priority Number:
139672 P
Priority Date:
22/12/2008
Priority Country:
United States (US)

2

Priority Number:
218530 P
Priority Date:
19/06/2009
Priority Country:
United States (US)

3

Priority Number:
246715 P
Priority Date:
29/09/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/135; A61K 31/137; A61K 31/138; A61K 31/661; A61P 37/00; A61P 37/06;

Publication

European Patent Bulletin

1

Issue number:
202023
Publication date:
03/06/2020
Description:
Grant (B1)

2

Issue number:
202114
Publication date:
07/04/2021
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/07/2020 Outgoing Correspondence 1
22/07/2020 Power Of Attorney 1